Condition
Maternal Exposure
Total Trials
7
Recruiting
2
Active
2
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 7 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 2 (1)
Trial Status
Completed3
Unknown2
Recruiting2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (7)
Showing 7 of 7 trials
NCT03851120Phase 2CompletedPrimary
Brain Probiotic and LC-PUFA Intervention for Optimum Early Life
NCT05889520Recruiting
The UFIM (Ultraprocessed Foods In Breast Milk) Project
NCT06617650RecruitingPrimary
GenerationGemelli: Longitudinal Study for the Evaluation of the Maternal Exposome on the Health of the Newborn and Child
NCT04721782Unknown
Effects of Maternal Smoking on Fetal Liver Circulation
NCT03783104Not ApplicableUnknown
Maternal B12 Supplementation to Improve Infant B12 Deficiency and Neurodevelopment
NCT03644355Not ApplicableCompleted
Asthma and Obesity Diet Versus Exercise
NCT00012428CompletedPrimary
Prenatal PCB Exposure
Showing all 7 trials